Publications
Detailed Information
Electrosprayed nanocomposites based on hyaluronic acid derivative and Soluplus for tumor-targeted drug delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Song Yi | - |
dc.contributor.author | Lee, Jeong-Jun | - |
dc.contributor.author | Park, Ju-Hwan | - |
dc.contributor.author | Lee, Jae-Young | - |
dc.contributor.author | Ko, Seung-Hak | - |
dc.contributor.author | Shim, Jae-Seong | - |
dc.contributor.author | Lee, Jongkook | - |
dc.contributor.author | Heo, Moon Young | - |
dc.contributor.author | Kim, Dae-Duk | - |
dc.contributor.author | Cho, Hyun-Jong | - |
dc.date.accessioned | 2024-04-26T00:26:39Z | - |
dc.date.available | 2024-04-26T00:26:39Z | - |
dc.date.created | 2017-11-15 | - |
dc.date.issued | 2016-09 | - |
dc.identifier.citation | Colloids and Surfaces B: Biointerfaces, Vol.145, pp.267-274 | - |
dc.identifier.issn | 0927-7765 | - |
dc.identifier.uri | https://hdl.handle.net/10371/199509 | - |
dc.description.abstract | Nanocomposite (NC) based on hyaluronic acid-ceramide (HACE) and Soluplus (SP) was fabricated by electrospraying for the tumor-targeted delivery of resveratrol (RSV). Amphiphilic property of both HACE and SP has been used to entrap RSV in the internal cavity of NC. Electrospraying with established experimental conditions produced HACE/SP/RSV NC with 230 nm mean diameter, narrow size distribution, negative zeta potential, and >80% drug entrapment efficiency. Sustained and pH-dependent drug release profiles were observed in drug release test. Cellular uptake efficiency of HACE/SP NC was higher than that of SP NC, mainly based on HA-CD44 receptor interaction, in MDA-MB-231 (CD44 receptor-positive human breast cancer) cells. Selective tumor targetability of HACE/SP NC, compared to SP NC, was also confirmed in MDA-MB-231 tumor-xenograted mouse model using a near-infrared fluorescence (NIRF) imaging. According to the results of pharmacokinetic study in rats, decreased in vivo clearance and increased halflife of RSV in NC group, compared to drug solution group, were shown. Given that these experimental results, developed HACE/SP NC can be a promising theranostic nanosystem for CD44 receptor-expressed cancers. (C) 2016 Elsevier B.V. All rights reserved. | - |
dc.language | 영어 | - |
dc.publisher | Elsevier BV | - |
dc.title | Electrosprayed nanocomposites based on hyaluronic acid derivative and Soluplus for tumor-targeted drug delivery | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.colsurfb.2016.05.009 | - |
dc.citation.journaltitle | Colloids and Surfaces B: Biointerfaces | - |
dc.identifier.wosid | 000381171800033 | - |
dc.identifier.scopusid | 2-s2.0-84968807646 | - |
dc.citation.endpage | 274 | - |
dc.citation.startpage | 267 | - |
dc.citation.volume | 145 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Lee, Jae-Young | - |
dc.contributor.affiliatedAuthor | Kim, Dae-Duk | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | SELF-ASSEMBLED NANOPARTICLES | - |
dc.subject.keywordPlus | SERUM-ALBUMIN NANOPARTICLES | - |
dc.subject.keywordPlus | BREAST-CANCER CELLS | - |
dc.subject.keywordPlus | TRANS-RESVERATROL | - |
dc.subject.keywordPlus | SOLID DISPERSIONS | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | RELEASE | - |
dc.subject.keywordPlus | BIOAVAILABILITY | - |
dc.subject.keywordPlus | FORMULATION | - |
dc.subject.keywordPlus | OPTIMIZATION | - |
dc.subject.keywordAuthor | CD44 receptor | - |
dc.subject.keywordAuthor | Electrospraying | - |
dc.subject.keywordAuthor | Nanocomposite | - |
dc.subject.keywordAuthor | Resveratrol | - |
dc.subject.keywordAuthor | Tumor targeting | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.